drugset / Trial / NCT07132515

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

NCT07132515

Phase 4 Recruiting 100 enrolled Mansoura University
Non-randomizedParallel-groupSingle-blindTreatment

Summary

We will give an anticoagulant against portal vein thrombosis, and watch for the results.

Timeline

Start
2023-08-15
Primary completion
2025-08
Completion
2025-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Apixaban Small molecule
Subject Enoxaparin sodium Other / unclassified
Subject warfarrin Unknown